Santhera Pharmaceuticals Logo

Santhera Pharmaceuticals

🇨🇭
SANN
CH1276028821

Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company based in Pratteln. It develops and markets treatments for rare neuromuscular diseases, including Duchenne muscular dystrophy. Its shares are listed on the SIX Swiss Exchange.

Next Quarterly Earnings

Tuesday, April 27, 2027
Expected

Stock Price

Frequently asked questions

When did Santhera Pharmaceuticals last report quarterly earnings?

Santhera Pharmaceuticals last reported quarterly earnings on 9/30/2026 (Q2 2026). Earnings per share (EPS) came in at -1.50 CHF.

How do I add the Santhera Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Missed
Estimate:-CHF 0.09
Actual:-CHF 1.50
Difference:-CHF 1.41
Price reaction (1 day):+2.8 %
Q1 2026
Estimate:—
Actual:-CHF 0.79
Price reaction (1 day):+1.0 %
Price reaction (7 days):-9.0 %

Company Information

Name
Santhera Pharmaceuticals
Ticker Symbol
SANN
ISIN
CH1276028821
Country
🇨🇭
Switzerland
Sector